chr2-151633944-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001164507.2(NEB):āc.9124T>Cā(p.Cys3042Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,613,354 control chromosomes in the GnomAD database, including 800,307 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.9124T>C | p.Cys3042Arg | missense_variant | 65/182 | ENST00000427231.7 | NP_001157979.2 | |
NEB | NM_001164508.2 | c.9124T>C | p.Cys3042Arg | missense_variant | 65/182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.9124T>C | p.Cys3042Arg | missense_variant | 65/182 | 5 | NM_001164508.2 | ENSP00000380505 | P5 | |
NEB | ENST00000427231.7 | c.9124T>C | p.Cys3042Arg | missense_variant | 65/182 | 5 | NM_001164507.2 | ENSP00000416578 | A2 | |
NEB | ENST00000409198.5 | c.8854-2766T>C | intron_variant | 5 | ENSP00000386259 |
Frequencies
GnomAD3 genomes AF: 0.977 AC: 148679AN: 152164Hom.: 72757 Cov.: 31
GnomAD3 exomes AF: 0.994 AC: 247644AN: 249042Hom.: 123170 AF XY: 0.996 AC XY: 134494AN XY: 135082
GnomAD4 exome AF: 0.998 AC: 1457917AN: 1461072Hom.: 727493 Cov.: 70 AF XY: 0.998 AC XY: 725414AN XY: 726706
GnomAD4 genome AF: 0.977 AC: 148796AN: 152282Hom.: 72814 Cov.: 31 AF XY: 0.978 AC XY: 72830AN XY: 74458
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 10, 2014 | This is a RefSeq error. The reference base (c.9124T) is the minor allele. This a llele (T) has been identified in 7.8% (108/1384) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs6710212) and thus meets criteria to be classified as benign. - |
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 27, 2017 | Variant summary: The NEB c.9124T>C (p.Cys3042Arg) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a benign outcome for this variant. This variant was found in 119893/120760 control chromosomes (59546 homozygotes) at a frequency of 0.9928205, which is approximately 281 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), suggesting this variant is the dominant allele. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 04, 2019 | - - |
Nemaline myopathy 2 Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 10, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Arthrogryposis multiplex congenita 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at